跳至主要内容
临床试验/IRCT2016062128559N1
IRCT2016062128559N1已完成3 期

Comparison of oral magnesium and placebo in migraine prophylaxis in pregnancy period

Vice-chancellor for research, Kermanshah University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • Diagnosis of migraine according to definition of International Headache Society by a neurologist; at least one year has passed form the time of migraine onset; moderate to severe headache; more than 2 headache attacks per month.
  • Exclusion criteria: Having tension headaches or other non-migraine headaches; overuse of analgesic medications (more than 15 days a month); use of any migraine prophylactic drugs; history of previous or recently infection; history of chronic diseases (diabetes, hypertension, cardiac, vascular, renal and hepatic); use of mineral supplements; substance and alcohol abuse.

排除标准

  • 未提供

研究者

发起方
Vice-chancellor for research, Kermanshah University of Medical Sciences

相似试验